Comparative Pharmacology
Head-to-head clinical analysis: NICODERM CQ versus NICORETTE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NICODERM CQ versus NICORETTE.
NICODERM CQ vs NICORETTE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Nicotine is a nicotinic cholinergic receptor agonist that stimulates ganglia and the CNS, leading to release of catecholamines and other neurotransmitters. In smoking cessation, it acts as a replacement therapy to reduce withdrawal symptoms and cravings by binding to nicotinic acetylcholine receptors in the brain.
Nicotine acts as an agonist at nicotinic acetylcholine receptors, stimulating the release of neurotransmitters such as dopamine and norepinephrine, which reduces withdrawal symptoms and cravings associated with smoking cessation.
Apply one 7 mg/24 hour, 14 mg/24 hour, or 21 mg/24 hour transdermal patch to non-hairy, clean, dry skin on the upper body or upper outer arm once daily. Initial dose based on smoking status: patients smoking >10 cigarettes/day: 21 mg/24 hours; patients smoking ≤10 cigarettes/day: 14 mg/24 hours. Titrate based on withdrawal symptoms.
Nicotine replacement therapy. For smoking cessation, chewing gum: 2 mg or 4 mg piece chewed slowly for 30 minutes every 1-2 hours as needed, maximum 24 pieces/day. Transdermal patch: Apply one 7 mg, 14 mg, or 21 mg/24 hour patch daily. Lozenge: 2 mg or 4 mg lozenge dissolved in mouth every 1-2 hours, maximum 20 lozenges/day. Inhaler: 6-16 cartridges/day. Nasal spray: 1-2 doses/hour, maximum 40 doses/day. All routes: typical duration 8-12 weeks.
None Documented
None Documented
Terminal elimination half-life ~2 hours (range 1-4 h) after transdermal patch removal; clinically, levels decline rapidly, requiring scheduled reapplication.
The terminal elimination half-life of nicotine is approximately 2 hours. This short half-life necessitates frequent dosing or continuous delivery to maintain therapeutic levels. Cotinine, the major metabolite, has a half-life of 15-20 hours.
Primarily renal; about 10-20% excreted unchanged, remainder as metabolites (cotinine and nicotine-N'-oxide). Total clearance ~1.2 L/min. Biliary/fecal excretion negligible (<5%).
Nicotine is extensively metabolized in the liver, primarily to cotinine. Renal excretion accounts for 2-35% of nicotine elimination unchanged, depending on urine pH (acidic urine increases excretion). Biliary/fecal excretion is minimal (<5%). Total clearance is about 1 L/min, with renal clearance of about 100 mL/min.
Category C
Category C
Smoking cessation aid
Smoking cessation aid